Navigation Links
CAPS Provides Input on Draft Sterile Compounding Legislation
Date:5/3/2013

BETHLEHEM, Pa., May 3, 2013 /PRNewswire/ -- Supporting consistent federal oversight of sterile compounding in the United States, Central Admixture Pharmacy Services, Inc. (CAPS®), a B. Braun company, submitted its comments today to the U.S. Senate Committee on Health, Education, Labor, and Pensions (HELP) regarding the committee's draft legislation on sterile compounding.

"We strongly believe that consistency will be the key," said Mike Koch , CAPS Vice President, Marketing and Support Services. "To help ensure both patient safety and confidence in the nation's drug supply, it's important to hold all compounded sterile preparations made in the U.S. to a consistent set of quality standards, while avoiding potentially dangerous loopholes."

CAPS delivers compounded sterile preparations daily, both locally and nationwide, from 25 locations. Included in the comments submitted to the Committee was support for the newly proposed "Compounding Manufacturer" category. CAPS looks forward to further engaging in the dialogue on this important patient safety legislation.

About CAPS

CAPS®, the nation's largest network of outsourcing admixture pharmacies, was pioneered in 1991 to deliver high-quality admixture services and solutions to a dynamic and challenging pharmacy environment. State-licensed and FDA-registered, CAPS pharmacies operate 365 days a year to dispense labeled, patient-specific and anticipatory IV prescriptions. To learn more about CAPS, visit www.capspharmacy.com.

About B. Braun

B. Braun Medical Inc. (B.Braun), a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. The Company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. Guided by its "Sharing Expertise®" philosophy, B.Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs.

The B.Braun Group of Companies in the U.S. includes B.Braun, Aesculap® and CAPS®. B.Braun's U.S. headquarters is located in Bethlehem, Pennsylvania. The B.Braun Group of Companies employs more than 46,000 employees in more than 50 countries throughout the world. To learn more about B.Braun visit www.BBraunUSA.com.


'/>"/>
SOURCE Central Admixture Pharmacy Services, Inc. (CAPS®), a B. Braun company
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Valeant Pharmaceuticals Provides Efinconazole Update
2. Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2013 Financial Results
3. OncoGenex Pharmaceuticals, Inc. Provides Clinical Development Program Overview and Reports Financial Results for First Quarter 2013
4. Haemonetics Reports 4th Quarter Fiscal 2013 Revenue Up 34% and Adjusted EPS of $0.48; Fourth Quarter and Full Year Organic Revenue Up 4% and Full Year Adjusted EPS of $1.71; Completes Hemerus Medical, LLC Acquisition and Provides Fiscal 2014 Guidanc
5. DietBrandReviews.com Provides a Comprehensive Review of the Dukan Diet
6. Hill-Rom Reports Fiscal Second Quarter Adjusted Earnings Per Share In Line With Expectations; Provides Third Quarter And Updated Full-Year Financial Outlook
7. Medical Alarm Concepts Files Information Statement and Provides Update on Corporate Activity
8. Hand-Held Device Provides Lab-Quality Troponin Test Results in 15 Minutes to Identify Patients Suspected of Heart Attack
9. Accuray Provides Clarification on Recently Initiated Voluntary Recalls
10. Centers for Specialty Care Group Provides On-Site Dialysis at Many of Its NYC Rehab Centers
11. DocuTrac, Inc. Provides Cloud Hosted Solution for Behavioral Health Providers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... 2016 The primary goal of this research ... on the usage of liquid biopsy. Key information the ... - Timeframe of liquid biopsy adoption amidst future users ... organization type - Sample inflow to conduct liquid biopsy ... serum, and so on. - Correlation analysis of sample ...
(Date:2/11/2016)... 11, 2016 PRO-DEX, INC. (NasdaqCM: PDEX) today announced ... 31, 2015. The Company also filed its Quarterly Report on ... with the Securities and Exchange Commission today. ... --> --> Net sales ... million, or 95%, to $5.4 million from $2.8 million for ...
(Date:2/11/2016)... -- Kindred Biosciences, Inc. (NASDAQ: KIN ), a biopharmaceutical ... pets, today announced the submission to FDA of the ... (NADA) for Zimeta™ (dipyrone injection, KIND-012).  Positive topline results ... the control of pyrexia (fever) in horses were recently ... --> The Chemistry, Manufacturing, and Controls technical ...
Breaking Medicine Technology:
(Date:2/13/2016)... ... February 13, 2016 , ... The producers of Enterprises TV ... , The increasingly modern world of instantaneous consumption proves very convenient for businesses. ... such as oil and coal, which pollutes our air, water, and soil. It can ...
(Date:2/13/2016)... , ... February 13, 2016 , ... ... Outlook’s top Clinical Data Management Solution Providers list for its expertise in eClinical ... and domain expertise to serve the technology needs of global clients. DDi provides ...
(Date:2/12/2016)... ... February 12, 2016 , ... ... exclusively to funding innovative lymphoma research and serving the lymphoma community through a ... 250 members of South Florida’s philanthropic community at its 10th anniversary Fashion Luncheon ...
(Date:2/12/2016)... ... ... Coco Libre, the maker of coconut water beverages with a purpose, is ... Coco Libre will offer musicians and celebrities the company’s signature Organic Coconut Water, a ... suite, held this year at the W Hollywood Hotel, has become a pre-show “must” ...
(Date:2/12/2016)... (PRWEB) , ... February 12, 2016 , ... Fisher House ... Vegas Mayor John J. Lee, Nevada Military Support Alliance president Scott Bensing, and Peggy ... at the VA Southern Nevada Healthcare System. This will be the first Fisher ...
Breaking Medicine News(10 mins):